Yellow Fever Vaccine Market: Future Demand and Top Key Players Analysis | 2029

 Focused on real-world business use, this report highlights what’s changing in the yellow fever vaccine market and what companies should prepare for next.

How Much Is The Yellow Fever Vaccine Market Worth?
The yellow fever vaccine market size has grown steadily in recent years. It will grow from $4.54 billion in 2024 to $4.74 billion in 2025 at a compound annual growth rate (CAGR) of 4.4%. The growth in the historic period can be attributed to the initiation of global immunization campaigns, implementation of international health regulations, mass vaccination campaigns, and advances in vaccine production technology.

The yellow fever vaccine market size is expected to see steady growth in the next few years. It will grow to $5.66 billion in 2029 at a compound annual growth rate (CAGR) of 4.5%. The growth in the forecast period can be attributed to increased collaboration and partnerships, integration with routine vaccination schedules, surveillance and monitoring, increasing involvement of the private sector, and adoption of digital technologies for vaccine tracking. Major trends in the forecast period include diversification of vaccine formats, pandemic preparedness, regulatory changes, healthcare infrastructure improvements, consumer education and awareness.

Get your free sample today:
Yellow Fever Vaccine Market Report 2025, Share & Outlook 2034 Sample

What Are The Current Leading Growth Drivers For Yellow Fever Vaccine Market?
Increasing international travel is expected to propel the growth of the yellow fever vaccine market going forward. International travel refers to the movement of individuals across country borders for purposes such as tourism, business, or personal reasons. International travel is rising due to increased global connectivity, economic growth, and the relaxation of travel restrictions post-pandemic. The yellow fever vaccine is required or recommended for travelers visiting regions where yellow fever is endemic to prevent infection and comply with international health regulations. For instance, in January 2024, according to the World Tourism Organization, a Spain-based agency, in 2023, there were 1.286 billion international tourists (overnight visitors) globally, while in 2022, there were 960 million international tourists (overnight visitors). This shows an increase of 326 million international tourists from 2022 to 2023. Therefore, increasing international travel is driving the growth of the yellow fever vaccine market.

Which Segment Accounted For The Largest Yellow Fever Vaccine Market Share?
The yellow fever vaccine market covered in this report is segmented –

1) By Product: Powder, Liquid
2) By Treatment Type: Pain Management Drugs, Oral Rehydration
3) By Application: Routine Immunization, Travelers, Other Applications
4) By End-User: Hospitals, Diagnostic Centers, Point Of Care Centers, Other End Users

Subsegments:
1) By Powder: Lyophilized Powder For Reconstitution, Freeze-Dried Powder For Reconstitution
2) By Liquid: Ready-To-Use Liquid Vaccine, Liquid Vaccine In Pre-Filled Syringes

What Are The Key Trends And Market Opportunities In The Yellow Fever Vaccine Sector?
Major companies operating in the yellow fever vaccine market are focusing on developing effective next-generation yellow fever vaccines, such as the T-cell adaptive booster vaccine, to meet an increasing global vaccine demand. A T-cell adaptive booster vaccine is a type of vaccine designed to enhance the immune system's memory T-cell response, providing prolonged and robust immunity against specific pathogens. For instance, in April 2022, Emergex Vaccines Holding Limited, a UK-based biotechnology company, partnered with ATCC, a US-based non-profit organization that provides reference microorganisms, cell lines, and other materials for research and development, to introduce CD8+ T-cell adaptive vaccines. These vaccines are specifically designed for yellow fever and aim to stimulate a potent cytotoxic T-cell response, which is essential for identifying and eliminating virus-infected cells. By promoting the production of memory CD8+ T-cells, these vaccines provide long-lasting and robust immunity. They focus on the cellular immune response rather than just antibody production, thus offering comprehensive protection against yellow fever and potentially enhancing effectiveness in individuals with different immune profiles.

Which Are The Top Companies To Hold The Market Share In Yellow Fever Vaccine Market?
Major companies operating in the yellow fever vaccine market are Merck and Co Inc., Sanofi S.A., GSK plc, Takeda Pharmaceutical Company, Lonza Group Ag, WuXi Biologics, Novavax Inc., Beijing Tiantan Biological, Bavarian Nordic A/S, Valneva SE, Biological E. Limited, Bio-Manguinhos, Instituto Butantan, Bio Farma, Panacea Biotec, Biovac, Institut Pasteur de Dakar, Ology Bioservices, Gavi, Wuhan Institute of Biological Products, PnuVax Incorporated, iBio Inc.

View the full yellow fever vaccine market report here:
Yellow Fever Vaccine Market Report 2025, Share & Outlook 2034

Which Region Is Projected To Account For The Largest Share Of The Yellow Fever Vaccine Market?
North America was the largest region in the yellow fever vaccine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the yellow fever vaccine market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

Contact Us:

The Business Research Company

Market Research Reports

Americas +1 310-496-7795
Asia +44 7882 955267 & +91 8897263534
Europe +44 7882 955267

Email: info@tbrc.info


Follow Us On:

LinkedIn: The Business Research Company | LinkedIn